Evidence map›Paper›PMID 26865666›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2016

Subacute Cardiovascular Toxicity of the Marine Phycotoxin Azaspiracid-1 in Rats.

Sara F Ferreiro, Natalia Vilariño, Cristina Carrera, M Carmen Louzao, Antonio G Cantalapiedra, Germán Santamarina, J Manuel Cifuentes, Andrés C Vieira, Luis M Botana

Open access · bronzeAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Sara F Ferreiro*Departamento de Farmacología luis.botana@usc.es natalia.vilarino@usc.es.
Natalia Vilariño*Departamento de Farmacología luis.botana@usc.es natalia.vilarino@usc.es.
Cristina Carrera*Departamento de Farmacología Hospital Veterinario Universitario Rof Codina.
M Carmen Louzao*Departamento de Farmacología.
Antonio G CantalapiedraHospital Veterinario Universitario Rof Codina Departamento de Ciencias Clínicas Veterinarias.
Germán SantamarinaHospital Veterinario Universitario Rof Codina Departamento de Ciencias Clínicas Veterinarias.
J Manuel CifuentesDepartamento de Anatomía y Producción Animal, Facultad de Veterinaria, Universidad de Santiago de Compostela, Lugo 27002, Spain.
Andrés C Vieira*Departamento de Farmacología.
Luis M Botana*Departamento de Farmacología luis.botana@usc.es natalia.vilarino@usc.es.
Universidade de Santiago de Compostela · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Azaspiracids (AZAs) are marine toxins produced by Azadinium spinosum that get accumulated in filter feeding shellfish through the food-web. The first intoxication was described in The Netherlands in 1990, and since then several episodes have been reported worldwide. Azaspiracid-1, AZA-2, and AZA-3 presence in shellfish is regulated by food safety authorities of several countries to protect human health. Azaspiracids have been related to widespread organ damage, tumorogenic properties and acute heart rhythm alterations in vivo but the mechanism of action remains unknown. Azaspiracid toxicity kinetics in vivo and in vitro suggests accumulative effects. We studied subacute cardiotoxicity in vivo after repeated exposure to AZA-1 by evaluation of the ECG, arterial blood pressure, plasmatic heart damage biomarkers, and myocardium structure and ultrastructure. Our results showed that four administrations of AZA-1 along 15 days caused functional signs of heart failure and structural heart alterations in rats at doses ranging from 1 to 55 µg/kg. Azaspiracid-1 altered arterial blood pressure, tissue inhibitors of metalloproteinase-1 plasma levels, heart collagen deposition, and ultrastructure of the myocardium. Overall, these data indicate that repeated exposure to low amounts of AZA-1 causes cardiotoxicity, at doses that do not induce signs of other organic system toxicity. Remarkably, human exposure to AZAs considering current regulatory limits of these toxins may be dangerously close to clearly cardiotoxic doses in rats. These findings should be considered when human risk is estimated particularly in high cardiovascular risk subpopulations.

Indexed as

AnimalsArterial PressureBiomarkersCardiotoxicityCollagenDose-Response Relationship, DrugFemaleHeart FailureHeart RateInflammation MediatorsMarine ToxinsMyocardiumPolyether ToxinsRats, Sprague-DawleyRisk AssessmentSpiro CompoundsazaspiracidBiomarkersCollagenInflammation MediatorsMarine ToxinsPolyether ToxinsSpiro Compoundsarterial blood pressureazaspiracidelectrocardiogramheart failure.subacute cardiotoxicityTIMP

Identifiers

PMID26865666
PMCPMC4914797
OpenAlexW2304500737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.